中信建投医药行业研究成果合集

中信建投证券研究
Sep 22

·重点行业报告·行业整体策略医药行业2025年投资策略:寻找新增量及整合机会医药生物2025年中期投资策略:立足于内,开拓于外创新药及产业链行业报告CXO:拐点显现,估值修复中国创新药:出海黄金时代,游到海水变蓝创新药2025中期策略:加速全球化NSCLC:肺癌慢病化之路新篇2025ASCO:中国创新,闪耀全球2025AACR、ASCO前瞻:高质量数据蓄势待发AI制药潜力释放,有望重塑医药未来图景...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10